The following adverse reactions have been identified during post approval use of sildenafil (marketed for both PAH and erectile dysfunction).When sexual stimulation causes local release of NO, inhibition of PDE-5 by sildenafil causes increased levels of cGMP in the corpus cavernosum, resulting in smooth muscle relaxation and inflow of blood to the